Ouahes T - Search Results

1

Structure-guided design of VAR2CSA-based immunogens and a cocktail strategy for a placental malaria vaccine.

Ma R, Salinas ND, Orr-Gonzalez S, Richardson B, Ouahes T, Torano H, Jenkins BJ, Dickey TH, Neal J, Duan J, Morrison RD, Gittis AG, Doritchamou JYA, Zaidi I, Lambert LE, Duffy PE, Tolia NH. Ma R, et al. Among authors: ouahes t. PLoS Pathog. 2024 Mar 4;20(3):e1011879. doi: 10.1371/journal.ppat.1011879. eCollection 2024 Mar. PLoS Pathog. 2024. PMID: 38437239 Free PMC article.

2

Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA.

Doritchamou J, Nielsen MA, Chêne A, Viebig NK, Lambert LE, Sander AF, Semblat JP, Hundt S, Orr-Gonzalez S, Janitzek CM, Spiegel AJ, Clemmensen SB, Thomas ML 3rd, Nason MC, Snow-Smith M, Barnafo EK, Shiloach J, Chen BB, Nadakal S, Highsmith K, Ouahes T, Conteh S, Sharma A, Torano H, Butler B, Reiter K, Rausch KM, Scaria PV, Anderson C, Narum DL, Salanti A, Fried M, Theander TG, Gamain B, Duffy PE. Doritchamou J, et al. Among authors: ouahes t. Lab Anim (NY). 2023 Dec;52(12):315-323. doi: 10.1038/s41684-023-01274-2. Epub 2023 Nov 6. Lab Anim (NY). 2023. PMID: 37932470 Free PMC article.

3

Structure-based design of a strain transcending AMA1-RON2L malaria vaccine.

Patel PN, Dickey TH, Diouf A, Salinas ND, McAleese H, Ouahes T, Long CA, Miura K, Lambert LE, Tolia NH. Patel PN, et al. Among authors: ouahes t. Nat Commun. 2023 Sep 2;14(1):5345. doi: 10.1038/s41467-023-40878-7. Nat Commun. 2023. PMID: 37660103 Free PMC article.

4

A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle.

Salinas ND, Ma R, Dickey TH, McAleese H, Ouahes T, Long CA, Miura K, Lambert LE, Tolia NH. Salinas ND, et al. Among authors: ouahes t. NPJ Vaccines. 2023 Aug 18;8(1):124. doi: 10.1038/s41541-023-00709-8. NPJ Vaccines. 2023. PMID: 37596283 Free PMC article.

5

Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines.

Dickey TH, Ma R, Orr-Gonzalez S, Ouahes T, Patel P, McAleese H, Butler B, Eudy E, Eaton B, Murphy M, Kwan JL, Salinas ND, Holbrook MR, Lambert LE, Tolia NH. Dickey TH, et al. Among authors: ouahes t. Cell Rep. 2023 Mar 28;42(3):112266. doi: 10.1016/j.celrep.2023.112266. Epub 2023 Mar 6. Cell Rep. 2023. PMID: 36943870 Free PMC article.

6

Design of a stabilized non-glycosylated Pfs48/45 antigen enables a potent malaria transmission-blocking nanoparticle vaccine.

Dickey TH, Gupta R, McAleese H, Ouahes T, Orr-Gonzalez S, Ma R, Muratova O, Salinas ND, Hume JCC, Lambert LE, Duffy PE, Tolia NH. Dickey TH, et al. Among authors: ouahes t. NPJ Vaccines. 2023 Feb 18;8(1):20. doi: 10.1038/s41541-023-00619-9. NPJ Vaccines. 2023. PMID: 36808125 Free PMC article.

7

Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response.

Dickey TH, Tang WK, Butler B, Ouahes T, Orr-Gonzalez S, Salinas ND, Lambert LE, Tolia NH. Dickey TH, et al. Among authors: ouahes t. Sci Adv. 2022 Sep 16;8(37):eabq8276. doi: 10.1126/sciadv.abq8276. Epub 2022 Sep 14. Sci Adv. 2022. PMID: 36103542 Free PMC article.

8

Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response.

Dickey TH, Tang WK, Butler B, Ouahes T, Orr-Gonzalez S, Salinas ND, Lambert LE, Tolia NH. Dickey TH, et al. Among authors: ouahes t. bioRxiv [Preprint]. 2021 May 10:2021.05.09.443238. doi: 10.1101/2021.05.09.443238. bioRxiv. 2021. PMID: 34013270 Free PMC article. Updated. Preprint.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page